Thursday Tailwinds #15: Nov 19, 2026
India’s 236 GWh battery target boosts local electrolyte-salt makers, while Mirion’s radiation monitors and Overwatch’s passive drone sensors ride nuclear and battlefield demand.
India’s 236 GWh battery target boosts local electrolyte-salt makers, while Mirion’s radiation monitors and Overwatch’s passive drone sensors ride nuclear and battlefield demand.
Call it a token gesture or not But how often do you see a founder put $30mm of his own personal money into buying his company’s bonds? Bonds quoted up this AM $CRWV
If you want to understand why $PDD trades at 4x PE (ex-cash), just try listening to the conference call. It's too painful, you won't make it.
Netflix’s $20 billion 2026 content budget spreads fixed costs across 325 million members, but generative AI and content abundance threaten…
Qualstar targets 8% revenue growth in 2027 and 12% in 2028 as AI-driven storage demand and LTO-10 replacement cycles revive tape libraries.
Sea Limited’s revenue rose 43% and adjusted EBITDA 29% in Q3 as slowing Shopee and stagnant Garena shift focus to Sea Cloud.
GFL’s halted sale process sets a $52 to $58 per-share range, while its Secure acquisition could redirect investor attention toward…
Euroseas’ feeder-vessel renewals and contracted cash flow support higher 2027 earnings, while Red Sea normalization, vessel values and…
Century Aluminum (CENX) could benefit from U.S. tariffs, Midwest aluminum premiums and constrained global supply, with the stock trading…
Figma grew Q3 revenue 43% to $391.4 million, raised FY2026 guidance to nearly $1.5 billion and guided Q4 above consensus despite the stock…
CDW CEO Chris Leahy says AI adoption has reached a make-or-break phase as customers seek trusted guidance amid proliferating IT choices.
S&P Global’s valuation swung from 7x earnings in 2009 to 50x in 2024 as ratings, indices and proprietary data expanded through acquisitions…
Amneal Pharmaceuticals posted its fourth straight earnings beat, with Q3 revenue up 10%, raised FY26 guidance and an expanding biosimilar…
ATS · long ATS Corporation is a turnaround under new leadership, targeting secular growth opportunities.
Netflix Q3 earnings update revises the thesis and rating.
Sagimet Biosciences' denifanstat enters a fully funded U.S. acne registration trial after Phase 3 results, with SGMT trading below cash and…
CoreWeave is compared with Amazon's early public years, when investors expected bankruptcy amid losses and dependence on outside capital.
Bending Spoons has spent about $10 billion on software acquisitions, including pending Miro, while Q2 organic growth was 3% and all…
Silvercorp’s falling Ying grades, prolonged GC suspension, El Domo execution risk and Chaarat funding needs weaken its valuation despite…
Snowflake says internal AI use is lifting revenue and profit, while customers show early implementation success.
Netflix’s earnings raise questions about whether its growth profile still merits a franchise valuation, alongside discussion of Disney’s…
Vicor’s $66.6 million in AI power-delivery royalties generated about $50 million of operating profit, eclipsing its module business as…
Inogen's $45 million buyback, debt-free balance sheet and cash equal to 61% of market value support a Buy case despite 3% 2026 growth…
Every publication on this site, hand-picked.
Every account on this site, hand-picked.
Ordered by how often our editor reaches for them.